Total Payments
$7,936
2024 Payments
$1,399
Companies
50
Transactions
528
Medicare Patients
2,002
Medicare Billing
$119,834
Payment Breakdown by Category
Food & Beverage$7,936 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,936 | 528 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,909 | 138 | $0 (2024) |
| Lilly USA, LLC | $543.07 | 37 | $0 (2024) |
| Novo Nordisk Inc | $536.28 | 45 | $0 (2024) |
| Astellas Pharma US Inc | $445.25 | 22 | $0 (2024) |
| Merck Sharp & Dohme LLC | $367.81 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $362.10 | 27 | $0 (2024) |
| PFIZER INC. | $336.35 | 21 | $0 (2024) |
| Amgen Inc. | $243.05 | 15 | $0 (2024) |
| Abbott Laboratories | $239.36 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $226.99 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,399 | 83 | ABBVIE INC. ($238.45) |
| 2023 | $1,225 | 71 | ABBVIE INC. ($254.22) |
| 2022 | $1,235 | 71 | ABBVIE INC. ($354.25) |
| 2021 | $1,378 | 87 | AbbVie Inc. ($503.34) |
| 2020 | $567.11 | 42 | AbbVie Inc. ($148.04) |
| 2019 | $570.30 | 49 | AbbVie, Inc. ($200.58) |
| 2018 | $733.47 | 61 | Novo Nordisk Inc ($190.65) |
| 2017 | $828.08 | 64 | Astellas Pharma US Inc ($145.32) |
All Payment Transactions
528 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $22.10 | General |
| Category: GI | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: VACCINES | ||||||
| 11/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Diabetes Care | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: VACCINE | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Biological | ||||||
| 10/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.58 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: VACCINE | ||||||
| 10/03/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 10/02/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Cardio-renal | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Biological | ||||||
| 09/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Bone Health | ||||||
| 09/11/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.62 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.16 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.18 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 489 | 634 | $226,590 | $27,796 |
| 2022 | 4 | 429 | 572 | $185,049 | $27,026 |
| 2021 | 4 | 431 | 598 | $181,962 | $36,893 |
| 2020 | 15 | 653 | 878 | $157,290 | $28,118 |
Total Patients
2,002
Total Services
2,682
Medicare Billing
$119,834
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 257 | 344 | $93,568 | $14,429 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 184 | $77,096 | $8,162 | 10.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 78 | $46,098 | $3,917 | 8.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $9,828 | $1,288 | 13.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 205 | 278 | $68,666 | $12,674 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 193 | $73,700 | $8,522 | 11.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 53 | 53 | $16,907 | $3,391 | 20.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 48 | $25,776 | $2,439 | 9.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 238 | 319 | $76,560 | $18,372 | 24.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 142 | 227 | $84,168 | $14,286 | 17.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $9,251 | $2,137 | 23.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 23 | $11,983 | $2,097 | 17.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 185 | 295 | $59,903 | $12,330 | 20.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 154 | 244 | $73,856 | $10,808 | 14.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 31 | 48 | $3,780 | $879.11 | 23.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 20 | 20 | $4,183 | $822.37 | 19.7% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 15 | 15 | $2,745 | $649.69 | 23.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $3,436 | $609.70 | 17.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 28 | 28 | $1,176 | $460.88 | 39.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 28 | 28 | $2,240 | $367.36 | 16.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 35 | 38 | $1,596 | $289.18 | 18.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 25 | 25 | $1,375 | $258.75 | 18.8% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 14 | 15 | $1,350 | $179.66 | 13.3% |
| 87880 | Strep test (streptococcus, group a) | Office | 2020 | 11 | 11 | $341.00 | $178.20 | 52.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 40 | 43 | $430.00 | $123.48 | 28.7% |
About Dr. Daniela Prada, MD
Dr. Daniela Prada, MD is a Internal Medicine healthcare provider based in Lyndhurst, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174598551.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniela Prada, MD has received a total of $7,936 in payments from pharmaceutical and medical device companies, with $1,399 received in 2024. These payments were reported across 528 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($7,936).
As a Medicare-enrolled provider, Prada has provided services to 2,002 Medicare beneficiaries, totaling 2,682 services with total Medicare billing of $119,834. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lyndhurst, OH
- Active Since 02/21/2006
- Last Updated 03/21/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174598551
Products in Payments
- LINZESS (Drug) $512.68
- ELIQUIS (Drug) $381.91
- UBRELVY (Drug) $353.45
- Creon (Drug) $328.58
- Kerendia (Drug) $226.99
- Myrbetriq (Drug) $216.37
- VRAYLAR (Drug) $196.47
- FARXIGA (Drug) $190.94
- TRULICITY (Drug) $171.98
- Linzess (Drug) $167.44
- TRADJENTA (Drug) $147.68
- CREON (Drug) $145.80
- EMGALITY (Drug) $142.48
- Vascepa (Drug) $141.14
- Ozempic (Drug) $136.98
- QULIPTA (Drug) $131.17
- VOQUEZNA (Drug) $124.99
- Prolia (Biological) $124.38
- AirDuo Digihaler (Drug) $120.54
- FREESTYLE LIBRE 3 (Device) $114.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lyndhurst
Dr. Stanislav Goykhman, M.d, M.D
Internal Medicine — Payments: $282,683
Internal Medicine $282,683
Dr. Vladlen Kim, Md, MD
Internal Medicine — Payments: $45,226
Internal Medicine $45,226
Marina Strizhevsky, Do, DO
Internal Medicine — Payments: $11,439
Internal Medicine $11,439
Marwa Hazzah, M.d, M.D
Internal Medicine — Payments: $3,516
Internal Medicine $3,516
Dr. Dorothy Bradford, Md, MD
Internal Medicine — Payments: $2,708
Internal Medicine $2,708
Dr. Amandeep Singh, Md, MD
Internal Medicine — Payments: $2,571
Internal Medicine $2,571